Cargando…
The Use of GLP1R Agonists for the Treatment of Type 2 Diabetes in Kidney Transplant Recipients
Glucagon-like peptide-1 receptor agonists (GLP1RA) have been shown to improve glucose control and diabetes-related comorbidities in patients without solid organ transplants. The effectiveness, safety, and tolerability of GLP1RA after kidney transplantation have not been adequately studied. METHODS....
Autores principales: | Kukla, Aleksandra, Hill, Jennifer, Merzkani, Massini, Bentall, Andrew, Lorenz, Elizabeth C., Park, Walter D., D’Costa, Matthew, Kudva, Yogish C., Stegall, Mark D., Shah, Pankaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004635/ https://www.ncbi.nlm.nih.gov/pubmed/32095510 http://dx.doi.org/10.1097/TXD.0000000000000971 |
Ejemplares similares
-
Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and Retransplantation
por: Balakrishnan, Suryanarayanan, et al.
Publicado: (2022) -
Death With Function and Graft Failure After Kidney Transplantation: Risk Factors at Baseline Suggest New Approaches to Management
por: Merzkani, Massini A., et al.
Publicado: (2022) -
Clinical and Kidney Structural Characteristics of Living Kidney Donors With Nephrolithiasis and Their Long-term Outcomes
por: D’Costa, Matthew R., et al.
Publicado: (2021) -
Long-term Immunosuppression Adherence After Kidney Transplant and Relationship to Allograft Histology
por: Lorenz, Elizabeth C., et al.
Publicado: (2018) -
The Relationship Between Health Literacy and Outcomes Before and After Kidney Transplantation
por: Lorenz, Elizabeth C., et al.
Publicado: (2022)